Value of plasma SN-38 levels and DPD activity in irinotecan-based individualized chemotherapy for advanced colorectal cancer with heterozygous type UGT1A1*6 or UGT1A1*28 | |
Tian, Chuan; Ying, Haifeng; Zhuang, Rongyuan; Zhang, Xiaowei; Lu, Hongmin; Wang, Hui; Wang, Shuowen; Li, Qi; Wang, Chungang; Cai, Xun | |
刊名 | CANCER MANAGEMENT AND RESEARCH |
2018 | |
卷号 | 10 |
关键词 | irinotecan pharmacokinetics enzyme activity uridine diphosphate glucuronosyl-transferase 1A1 colorectal cancer |
ISSN号 | 1179-1322 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3610030 |
专题 | 复旦大学上海医学院 |
推荐引用方式 GB/T 7714 | Tian, Chuan,Ying, Haifeng,Zhuang, Rongyuan,et al. Value of plasma SN-38 levels and DPD activity in irinotecan-based individualized chemotherapy for advanced colorectal cancer with heterozygous type UGT1A1*6 or UGT1A1*28[J]. CANCER MANAGEMENT AND RESEARCH,2018,10. |
APA | Tian, Chuan.,Ying, Haifeng.,Zhuang, Rongyuan.,Zhang, Xiaowei.,Lu, Hongmin.,...&Cai, Xun.(2018).Value of plasma SN-38 levels and DPD activity in irinotecan-based individualized chemotherapy for advanced colorectal cancer with heterozygous type UGT1A1*6 or UGT1A1*28.CANCER MANAGEMENT AND RESEARCH,10. |
MLA | Tian, Chuan,et al."Value of plasma SN-38 levels and DPD activity in irinotecan-based individualized chemotherapy for advanced colorectal cancer with heterozygous type UGT1A1*6 or UGT1A1*28".CANCER MANAGEMENT AND RESEARCH 10(2018). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论